Leora Horn

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

1. Advances in the treatment of non-small cell lung cancer. Horn L (2014) J Natl Compr Canc Netw 12(5 Suppl): 764-7
   › Primary publication · 24853212 (PubMed)
2. Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1. Pirazzoli V, Nebhan C, Song X, Wurtz A, Walther Z, Cai G, Zhao Z, Jia P, de Stanchina E, Shapiro EM, Gale M, Yin R, Horn L, Carbone DP, Stephens PJ, Miller V, Gettinger S, Pao W, Politi K (2014) Cell Rep 7(4): 999-1008
   › Primary publication · 24813888 (PubMed) · PMC4074596 (PubMed Central)
3. Enabling a genetically informed approach to cancer medicine: a retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panel. Johnson DB, Dahlman KH, Knol J, Gilbert J, Puzanov I, Means-Powell J, Balko JM, Lovly CM, Murphy BA, Goff LW, Abramson VG, Crispens MA, Mayer IA, Berlin JD, Horn L, Keedy VL, Reddy NM, Arteaga CL, Sosman JA, Pao W (2014) Oncologist 19(6): 616-22
   › Primary publication · 24797823 (PubMed) · PMC4041676 (PubMed Central)
4. Phase II study of bendamustine in relapsed chemotherapy sensitive or resistant small-cell lung cancer. Lammers PE, Shyr Y, Li CI, Hutchison AS, Sandler A, Carbone DP, Johnson DH, Keedy VL, Horn L (2014) J Thorac Oncol 9(4): 559-62
   › Primary publication · 24736081 (PubMed) · PMC3990869 (PubMed Central)
5. Satisfaction with work-life balance and the career and retirement plans of US oncologists. Shanafelt TD, Raymond M, Kosty M, Satele D, Horn L, Pippen J, Chu Q, Chew H, Clark WB, Hanley AE, Sloan J, Gradishar WJ (2014) J Clin Oncol 32(11): 1127-35
   › Primary publication · 24616305 (PubMed) · PMC4876331 (PubMed Central)
6. Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma. Imielinski M, Greulich H, Kaplan B, Araujo L, Amann J, Horn L, Schiller J, Villalona-Calero MA, Meyerson M, Carbone DP (2014) J Clin Invest 124(4): 1582-6
   › Primary publication · 24569458 (PubMed) · PMC3973082 (PubMed Central)
7. Reducing lung cancer mortality: 2014 update. Horn L, Carbone DP (2014) Semin Oncol 41(1): 3-4
   › Primary publication · 24565576 (PubMed)
8. Burnout and career satisfaction among US oncologists. Shanafelt TD, Gradishar WJ, Kosty M, Satele D, Chew H, Horn L, Clark B, Hanley AE, Chu Q, Pippen J, Sloan J, Raymond M (2014) J Clin Oncol 32(7): 678-86
   › Primary publication · 24470006 (PubMed) · PMC3927737 (PubMed Central)
9. A patient with metastatic lung adenocarcinoma harboring concurrent EGFR L858R, EGFR germline T790M, and PIK3CA mutations: the challenge of interpreting results of comprehensive mutational testing in lung cancer. Lammers PE, Lovly CM, Horn L (2014) J Natl Compr Canc Netw 12(1): 6-11; quiz 11
   › Primary publication · 24453288 (PubMed) · PMC4151469 (PubMed Central)
10. Targeting angiogenesis in advanced non-small cell lung cancer. Lammers PE, Horn L (2013) J Natl Compr Canc Netw 11(10): 1235-47
    › Primary publication · 24142825 (PubMed) · PMC6628716 (PubMed Central)
11. A 75-year-old man with progressive bronchioalveolar carcinoma. Baikadi M, Lovly C, Horn L, Reckamp KL, Noonan K, Laskin J, Morris GJ (2013) Semin Oncol 40(1): e1-8
    › Primary publication · 23391120 (PubMed) · PMC6607023 (PubMed Central)
12. Update on HER1-3 in advanced non-small-cell lung cancer. Horn L, Lovly C (2012) J Thorac Oncol 7(16 Suppl 5): S369-71
    › Primary publication · 23160321 (PubMed)
13. Non-small cell lung cancer. Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, Govindan R, Grannis FW, Horn L, Jahan TM, Jahanzeb M, Kessinger A, Komaki R, Kong FM, Kris MG, Krug LM, Lennes IT, Loo BW, Martins R, O'Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Pinder-Schenck MC, Pisters KM, Reckamp K, Riely GJ, Rohren E, Swanson SJ, Wood DE, Yang SC, Hughes M, Gregory KM, NCCN (National Comprehensive Cancer Network) (2012) J Natl Compr Canc Netw 10(10): 1236-71
    › Primary publication · 23054877 (PubMed)
14. Identifying barriers associated with enrollment of patients with lung cancer into clinical trials. Horn L, Keedy VL, Campbell N, Garcia G, Hayes A, Spencer B, Carbone DP, Sandler A, Johnson DH (2013) Clin Lung Cancer 14(1): 14-8
    › Primary publication · 22591607 (PubMed)
15. Malignant pleural mesothelioma. Ettinger DS, Akerley W, Borghaei H, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, Govindan R, Grannis FW, Horn L, Jahan TM, Jahanzeb M, Kessinger A, Komaki R, Kong FM, Kris MG, Krug LM, Lennes IT, Loo BW, Martins R, O'Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Schenck MP, Pisters KM, Reckamp K, Riely GJ, Rohren E, Swanson SJ, Wood DE, Yang SC, National Comprehensive Cancer Network (2012) J Natl Compr Canc Netw 10(1): 26-41
    › Primary publication · 22223867 (PubMed)
16. Factors associated with the career choices of hematology and medical oncology fellows trained at academic institutions in the United States. Horn L, Koehler E, Gilbert J, Johnson DH (2011) J Clin Oncol 29(29): 3932-8
    › Primary publication · 21911716 (PubMed) · PMC3189092 (PubMed Central)
17. Molecular predictors of response to chemotherapy in non-small cell lung cancer. Andrews J, Yeh P, Pao W, Horn L (2011) Cancer J 17(2): 104-13
    › Primary publication · 21427554 (PubMed)
18. Update on new drugs in small cell lung cancer. Horn L, Castellanos EL, Johnson DH (2011) Expert Opin Investig Drugs 20(4): 441-5
    › Primary publication · 21395484 (PubMed)
19. Ephraim McDowell, the first ovariotomy, and the birth of abdominal surgery. Horn L, Johnson DH (2010) J Clin Oncol 28(7): 1262-8
    › Primary publication · 20124170 (PubMed)
20. Authorship and industry financial relationships: the tie that binds. Johnson DH, Horn L (2010) J Clin Oncol 28(8): 1281-3
    › Primary publication · 20065171 (PubMed)
21. EML4-ALK: honing in on a new target in non-small-cell lung cancer. Horn L, Pao W (2009) J Clin Oncol 27(26): 4232-5
    › Primary publication · 19667260 (PubMed)
22. Angiogenesis in the treatment of non-small cell lung cancer. Horn L, Sandler AB (2009) Proc Am Thorac Soc 6(2): 206-17
    › Primary publication · 19349490 (PubMed) · PMC5820832 (PubMed Central)
23. Lung cancer adjuvant therapy. Horn L, Sandler A (2007) Cancer J 13(3): 210-6
    › Primary publication · 17620772 (PubMed)
24. Docetaxel in non-small cell lung cancer: impact on quality of life and pharmacoeconomics. Horn L, Visbal A, Leighl NB (2007) Drugs Aging 24(5): 411-28
    › Primary publication · 17503897 (PubMed)
25. The rationale for adjuvant chemotherapy in stage I non-small cell lung cancer. Horn L, Sandler AB, Putnam JB, Johnson DH (2007) J Thorac Oncol 2(5): 377-83
    › Primary publication · 17473651 (PubMed)

Keywords & MeSH Terms

MeSH terms are retrieved from PubMed records. Learn more.

Key: MeSH Term Keyword